ANAPTYSBIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-35.2M | $51.7M |
| FY2016 | — | $-38.2M | $51.2M |
| FY2017 | — | $307.6M | $81.2M |
| FY2018 | — | $486.4M | $113.6M |
| FY2019 | — | $405.0M | $171.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-35.2M | $51.7M |
| FY2016 | — | $-38.2M | $51.2M |
| FY2017 | — | $307.6M | $81.2M |
| FY2018 | — | $486.4M | $113.6M |
| FY2019 | — | $405.0M | $171.0M |